FDA Drug · D-0868-2026

Exenatide Injection, USP, 250 mcg/mL, 1.2 mL per prefilled pen, Rx Only, Subcutaneous Use Only, For Single Patient Use Only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Ahmedabad 382213, India; Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 70121-1685-1

Class II · Ongoing

Defective Delivery System: Possibility of no medication in the prefilled pen.

Affected lots / codes — check yours against thisLot #: AP250095A, Exp 2/28/2027

Recalling firm: Amneal Pharmaceuticals of New York, LLC, Brookhaven, NY
Classification: Class II (temporary or reversible harm possible)
Status: Ongoing
Quantity: 5,694 pens
Distribution: USA Nationwide
Recall initiated: August 28, 2026
Classified: September 22, 2026
Initiation: Voluntary: Firm initiated

Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0868-2026%22

Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.

Check this brand across all 8 databases →